journal article·2024-08-09Open access

Exploring Platelet-Rich Plasma Therapy for Knee Osteoarthritis: An In-Depth Analysis

Florin Nicolae Blaga, Alexandru Stefan Nutiu, Alex Octavian Lupsa, Nicu Adrian Ghiurau, Silviu Valentin Vlad, Timea Claudia Ghitea

Abstract

The use of platelet-rich plasma (PRP) in all medical fields is currently gaining popularity (1). PRP is a biological product that can be defined as a segment of the plasma fraction of autologous blood with a platelet concentration level above the baseline (2). The fact that it has uses in tissue regeneration and wound healing has caught the eye of orthopedic surgeons as well, as intra-articular treatments have continued to evolve. Its benefits in the treatment of different osteoarticular pathologies are of great interest in the evolving orthopedic community, targeting mostly knee osteoarthritis, meniscus and ligament injuries (3). The purpose of this review is to update the reader on the current uses of platelet-rich plasma (PRP) in the treatment of knee osteoarthritis pathology and to provide clinical feedback on its uses in the fields of orthopedic and sports medicine practice (4). We proceeded in studying 180 titles and abstracts eligible for inclusion. Compared to alternative treatments, PRP injections greatly improve the function of the knee joint.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Periodontal Regeneration and Treatments · Knee injuries and reconstruction techniques · Tendon Structure and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

County Clinical Emergency Hospital of Oradea, 65 Gheorghe Doja Street, 410169 Oradea, Romania

Department of Surgical Specialties, Faculty of Medicine and Pharmacy, University of Oradea, 10 1st Decembrie Street, 410073 Oradea, Romania

Pharmacy Department, Faculty of Medicine and Pharmacy, University of Oradea, 10 1st Decembrie Street, 410073 Oradea, Romania

Funding

University of Oradea

References (100+)

Show source-provided references
1. Knee Osteoarthritis: A Primer10.7812/TPP/16-183 ↗
2. Female hormonal factors and osteoarthritis of the knee, hip and hand: A narrative review10.1080/13697137.2017.1421926 ↗
3. Management of osteoarthritis of the knee10.1136/bmj.e4934 ↗
4. Design of patient-specific gait modifications for knee osteoarthritis rehabilitation10.1109/TBME.2007.891934 ↗
5. Weight loss reduces knee-joint loads in overweight and obese older adults with knee osteoarthritis10.1002/art.21139 ↗
6. The challenges of treating osteoarthritis pain and opportunities for novel peripherally directed therapeutic strategies10.1016/j.neuropharm.2022.109075 ↗
7. Knee pain, knee injury, knee osteoarthritis & work10.1016/j.berh.2015.05.005 ↗
8. Nistor-Cseppento, C.D., Gherle, A., Negrut, N., Bungau, S.G., Sabau, A.M., Radu, A.-F., Bungau, A.F., Tit, D.M., Uivaraseanu, B., and Ghitea, T.C. (2022). The Outcomes of Robotic Rehabilitation Assisted Devices Following Spinal Cord Injury and the Prevention of Secondary Associated Complications. Medicina, 58.10.3390/medicina58101447 ↗
9. Pellegrino, R., Paolucci, T., Brindisino, F., Mondardini, P., Di Iorio, A., Moretti, A., and Iolascon, G. (2022). Effectiveness of High-Intensity Laser Therapy Plus Ultrasound-Guided Peritendinous Hyaluronic Acid Compared to Therapeutic Exercise for Patients with Lateral Elbow Tendinopathy. J. Clin. Med., 11.10.3390/jcm11195492 ↗
10. Combined ultrasound guided peritendinous hyaluronic acid (500–730 Kda) injection with extracorporeal shock waves therapy vs. extracorporeal shock waves therapy-only in the treatment of shoulder pain due to rotator cuff tendinopathy. A randomized clinical trial
11. Navigating the Therapeutic Landscape: A Comprehensive Review of Platelet-Rich Plasma and Bone Marrow Aspirate Concentrate in Knee Osteoarthritis
12. Injectable hydrogels: An emerging therapeutic strategy for cartilage regeneration10.1016/j.cis.2023.103030 ↗
13. Autologous platelet-rich-plasma injection and platelet-rich fibrin glue interposition for treatment of anal fistula resistant to surgery
14. Therapeutic uses of platelet-rich plasma (PRP) in sport injuries—A narrative review10.1016/j.jorep.2023.100287 ↗
15. Bec, C., Rousset, A., Brandin, T., François, P., Rabarimeriarijaona, S., Dumoulin, C., Heleu, G., Grimaud, F., Veran, J., and Magalon, G. (2021). A Retrospective Analysis of Characteristic Features of Responders and Impaired Patients to a Single Injection of Pure Platelet-Rich Plasma in Knee Osteoarthritis. J. Clin. Med., 10.10.3390/jcm10081748 ↗
17. Primorac, D., Molnar, V., Matišić, V., Hudetz, D., Jeleč, Ž., Rod, E., Čukelj, F., Vidović, D., Vrdoljak, T., and Dobričić, B. (2021). Comprehensive Review of Knee Osteoarthritis Pharmacological Treatment and the Latest Professional Societies’ Guidelines. Pharmaceuticals, 14.10.3390/ph14030205 ↗
18. An update on the pathophysiology of osteoarthritis10.1016/j.rehab.2016.07.004 ↗
19. Pathophysiology of osteoarthritis10.1016/j.joca.2003.10.002 ↗
20. Etiopathogenesis of osteoarthritis10.1016/j.rdc.2008.05.011 ↗
21. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis10.1172/JCI118636 ↗
22. Boehme, K.A., and Rolauffs, B. (2018). Onset and progression of human osteoarthritis—Can growth factors, inflammatory cytokines, or differential miRNA expression concomitantly induce proliferation, ECM degradation, and inflammation in articular cartilage?. Int. J. Mol. Sci., 19.10.3390/ijms19082282 ↗
23. Aggrecanolysis in human osteoarthritis: Confocal localization and biochemical characterization of ADAMTS5–hyaluronan complexes in articular cartilages10.1016/j.joca.2006.12.008 ↗
24. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis10.1155/2014/561459 ↗
25. Predominant activation of MAP kinases and pro-destructive/pro-inflammatory features by TNF α in early-passage synovial fibroblasts via TNF receptor-1: Failure of p38 inhibition to suppress matrix metalloproteinase-1 in rheumatoid arthritis10.1136/ard.2006.062521 ↗
26. Aging and osteoarthritis: A different perspective10.1097/00002281-200309000-00016 ↗
27. Epidemiology of osteoarthritis10.1016/j.rdc.2012.10.004 ↗
28. Role of oxidative stress in rheumatoid arthritis: Insights from the Nrf2-knockout mice10.1136/ard.2010.132720 ↗
29. PRP in OA knee—Update, current confusions and future options10.1051/sicotj/2017004 ↗
30. Osteoarthritis of the knee and hip. Part I: Aetiology and pathogenesis as a basis for pharmacotherapy10.1111/j.2042-7158.2012.01458.x ↗
31. PRP for Degenerative Cartilage Disease: A Systematic Review of Clinical Studies10.1177/1947603516670709 ↗
32. Szwedowski, D., Szczepanek, J., Paczesny, Ł., Zabrzyński, J., Gagat, M., Mobasheri, A., and Jeka, S. (2021). The Effect of Platelet-Rich Plasma on the Intra-Articular Microenvironment in Knee Osteoarthritis. Int. J. Mol. Sci., 22.10.3390/ijms22115492 ↗
33. Fernandes, G.S., Sarmanova, A., Warner, S., Harvey, H., Akin-Akinyosoye, K., Richardson, H., Frowd, N., Marshall, L., Stocks, J., and Hall, M. (2017). Knee pain and related health in the community study (KPIC): A cohort study protocol. BMC Musculoskelet. Disord., 18.10.1186/s12891-017-1761-4 ↗
34. Discoid lateral meniscus and the frequency of meniscal tears10.1007/s002560100351 ↗
35. Impact of type of meniscal tear on radiographic and symptomatic knee osteoarthritis: A sixteen-year followup of meniscectomy with matched controls10.1002/art.11088 ↗
36. Effect of meniscal damage on the development of frequent knee pain, aching, or stiffness10.1002/art.23071 ↗
37. The long-term consequence of anterior cruciate ligament and meniscus injuries: Osteoarthritis10.1177/0363546507307396 ↗
38. Charlesworth, J., Fitzpatrick, J., Perera, N.K.P., and Orchard, J. (2019). Osteoarthritis- a systematic review of long-term safety implications for osteoarthritis of the knee. BMC Musculoskelet. Disord., 20.10.1186/s12891-019-2525-0 ↗
39. The influence of diet therapeutic intervention on the sarcopenic index of patients with metabolic syndrome
40. Effects of dietary intervention and quadriceps strengthening exercises on pain and function in overweight people with knee pain: Randomised controlled trial10.1136/bmj.b3170 ↗
41. Is Weight Loss Associated with Less Progression of Changes in Knee Articular Cartilage among Obese and Overweight Patients as Assessed with MR Imaging over 48 Months? Data from the Osteoarthritis Initiative10.1148/radiol.2017161005 ↗
42. Exercise for osteoarthritis of the knee
43. Land-based exercise for osteoarthritis of the knee: A metaanalysis of randomized controlled trials10.3899/jrheum.090058 ↗
44. Treatment of knee osteoarthritis
45. Effect of physical activity and dietary restriction interventions on weight loss and the musculoskeletal function of overweight and obese older adults with knee osteoarthritis: A systematic review and mixed method data synthesis10.1136/bmjopen-2016-014537 ↗
46. Lifetime risk and age of diagnosis of symptomatic knee osteoarthritis in the US10.1002/acr.21898 ↗
47. Safety and efficacy of S-adenosylmethionine (SAMe) for osteoarthritis
48. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: A randomized, double-blind, placebo-controlled trial10.1002/art.10777 ↗
49. A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification10.1159/000477353 ↗
50. Theml, H., Diem, H., and Haferlach, T. (2004). Color Atlas of Hematology: Practical Microscopic and Clinical Diagnosis, Thieme.10.1055/b-005-148949 ↗
51. Current clinical recommendations for use of platelet-rich plasma10.1007/s12178-018-9527-7 ↗
52. Platelet-rich plasma: Underlying biology and clinical correlates10.2217/rme.13.59 ↗
53. Ultrasound-guided platelet-rich-plasma injections for reducing sacroiliac joint pain: A paradigmatic case report and literature review10.3233/BMR-210310 ↗
54. Biologic and pharmacologic augmentation of rotator cuff repairs10.5435/00124635-201110000-00002 ↗
55. Growth factor delivery methods in the management of sports injuries: The state of play10.1136/bjsm.2007.040071 ↗
56. Role of platelet-rich plasma in soft and hard connective tissue healing: An evidence based review from basic to clinical application10.13172/2050-2303-2-1-326 ↗
57. Platelet Rich Plasma-A Healing Aid and Perfect Enhancement Factor: Review and Case Report10.5005/jp-journals-10005-1085 ↗
58. The role of platelet-rich plasma in musculoskeletal science10.1258/shorts.2011.011148 ↗
59. Principles and Methods of Preparation of Platelet-Rich Plasma: A Review and Author’s Perspective10.4103/0974-2077.150734 ↗
60. Platelet Rich Plasma: A short overview of certain bioactive components10.1515/med-2016-0048 ↗
61. Application of platelet-rich plasma in sports medicine10.2478/v10078-011-0076-z ↗
62. Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine10.1080/09537104.2020.1832653 ↗
63. Platelet-rich plasma in dermatology: Boon or a bane?10.4103/0378-6323.125467 ↗
64. Classification of platelet concentrates: From pure platelet-rich plasma (P-PRP) to leucocyte-and platelet-rich fibrin (L-PRF)10.1016/j.tibtech.2008.11.009 ↗
65. Improvising PRP for use in osteoarthritis knee-upcoming trends and futuristic view10.1016/j.jcot.2018.10.005 ↗
66. Platelet-rich plasma preparation using three devices: Implications for platelet activation and platelet growth factor release10.1080/08977190600821327 ↗
67. Du, L., Miao, Y., Li, X., Shi, P., and Hu, Z. (2018). A novel and convenient method for the preparation and activation of PRP without any additives: Temperature controlled PRP. BioMed Res. Int., 2018.10.1155/2018/1761865 ↗
68. Cavallo, C., Roffi, A., Grigolo, B., Mariani, E., Pratelli, L., Merli, G., Kon, E., Marcacci, M., and Filardo, G. (2016). Platelet-rich plasma: The choice of activation method affects the release of bioactive molecules. BioMed Res. Int., 2016.10.1155/2016/6591717 ↗
69. Bansal, H., Leon, J., Pont, J.L., Wilson, D.A., Bansal, A., Agarwal, D., and Preoteasa, I. (2021). Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy. Sci. Rep., 11.10.1038/s41598-021-83025-2 ↗
70. A mechanistic model of platelet-rich plasma treatment for androgenetic alopecia10.1097/DSS.0000000000000901 ↗
71. Releasing growth factors from activated human platelets after chitosan stimulation: A possible bio-material for platelet-rich plasma preparation10.1111/j.1600-0501.2004.01241.x ↗
72. Freeze dried chitosan/platelet-rich-plasma implants improve marrow stimulated cartilage repair in rabbit chronic defect model
73. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis10.1177/0363546513507766 ↗
74. Platelet-rich plasma releasate inhibits inflammatory processes in osteoarthritic chondrocytes10.1177/0363546511419278 ↗
75. The efficacy of platelet-rich plasma on tendon and ligament healing: A systematic review and meta-analysis with bias assessment10.1177/0363546517743746 ↗
76. Kabiri, A., Esfandiari, E., Esmaeili, A., Hashemibeni, B., Pourazar, A., and Mardani, M. (2014). Platelet-rich plasma application in chondrogenesis. Adv. Biomed. Res., 3.10.4103/2277-9175.135156 ↗
77. Platelet-rich plasma (PRP) to treat sports injuries: Evidence to support its use10.1007/s00167-010-1306-y ↗
78. The effect of platelet-rich plasma on the regenerative therapy of muscle derived stem cells for articular cartilage repair10.1016/j.joca.2012.09.018 ↗
79. Efficacy of Intra-articular Platelet-Rich Plasma Injections in Knee Osteoarthritis: A Systematic Review10.1016/j.arthro.2015.08.005 ↗
80. The contribution of platelet-derived growth factor, transforming growth factor-beta1, and insulin-like growth factor-I in platelet-rich plasma to the proliferation of osteoblast-like cells10.1016/j.tripleo.2005.08.016 ↗
81. Filardo, G., Kon, E., Di Martino, A., Di Matteo, B., Merli, M.L., Cenacchi, A., Fornasari, P.M., and Marcacci, M. (2012). Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: Study design and preliminary results of a randomized controlled trial. BMC Musculoskelet. Disord., 13.10.1186/1471-2474-13-229 ↗
82. Short-term outcomes of platelet-rich plasma injection for treatment of osteoarthritis of the knee10.1007/s00167-015-3784-4 ↗
83. Platelet-rich plasma versus hyaluronic acid in the treatment of knee osteoarthritis: A meta-analysis10.1186/s13018-020-01919-9 ↗
84. Comparison between intra-articular infiltrations of placebo, steroids, hyaluronic and PRP for knee osteoarthritis: A Bayesian network meta-analysis10.1007/s00402-020-03551-y ↗
85. Moretti, L., Maccagnano, G., Coviello, M., Cassano, G.D., Franchini, A., Laneve, A., and Moretti, B. (2022). Platelet Rich Plasma Injections for Knee Osteoarthritis Treatment: A Prospective Clinical Study. J. Clin. Med., 11.10.3390/jcm11092640 ↗
86. Intra-articular injections of platelet-rich plasma, hyaluronic acid or corticosteroids for knee osteoarthritis: A prospective randomized controlled study10.1007/s00132-018-03659-5 ↗
87. Platelet-rich plasma (PRP) injections as an effective treatment for early osteoarthritis10.1007/s00590-012-1037-5 ↗
88. Treatment of knee chondropathy with platelet-rich plasma. Preliminary results at 6 months of follow-up with only one injection
89. Platelet-rich plasma in patients with tibiofemoral cartilage degeneration10.1007/s00402-013-1782-x ↗
90. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: A prospective, double-blind, randomized trial10.1177/0363546512471299 ↗
91. Platelet-rich plasma (PRP) applied during total knee arthroplasty10.1016/j.rbo.2014.05.005 ↗
92. Attia, S., Narberhaus, C., Schaaf, H., Streckbein, P., Pons-Kühnemann, J., Schmitt, C., Neukam, F.W., Howaldt, H.-P., and Böttger, S. (2020). Long-Term Influence of Platelet-Rich Plasma (PRP) on Dental Implants after Maxillary Augmentation: Implant Survival and Success Rates. J. Clin. Med., 9.10.3390/jcm9020391 ↗
93. Shu, H., Huang, Z., Bai, X., Xia, Z., Wang, N., Fu, X., Cheng, X., and Zhou, B. (2022). The Application of Platelet-Rich Plasma for Patients Following Total Joint Replacement: A Meta-Analysis of Randomized Controlled Trials and Systematic Review. Front. Surg., 9.10.3389/fsurg.2022.922637 ↗
94. Platelet-Rich Plasma (PRP) and Tranexamic Acid (TXA) Applied in Total Knee Arthroplasty10.1590/1413-785220192705214417 ↗
95. Intraoperative Platelet Rich Plasma Usage in Total Knee Arthroplasty: Does It Help?10.1155/2013/740173 ↗
96. Platelet Rich Plasma (PRP) Application in Total Knee Arthroplasty (TKA)
97. Li, T., Li, Y., Li, W., Wang, X., Ding, Q., Gao, J., Zhang, Y., and Zhuang, W. (2023). Impact of autologous platelet-rich plasma therapy vs. hyaluronic acid on synovial fluid biomarkers in knee osteoarthritis: A Randomized controlled clinical trial. Front. Med., 10.10.3389/fmed.2023.1258727 ↗
98. Everts, P., Onishi, K., Jayaram, P., Lana, J.F., and Mautner, K. (2020). Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020. Int. J. Mol. Sci., 21.10.20944/preprints202010.0069.v1 ↗
99. Phase I/II Clinical Trial of Autologous Activated Platelet-Rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients
100. Lacko, M., Harvanová, D., Slovinská, L., Matuška, M., Balog, M., Lacková, A., Špaková, T., and Rosocha, J. (2021). Effect of Intra-Articular Injection of Platelet-Rich Plasma on the Serum Levels of Osteoarthritic Biomarkers in Patients with Unilateral Knee Osteoarthritis. J. Clin. Med., 10.10.3390/jcm10245801 ↗